Steven Cohen's BRKR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.06 M shares of Bruker Corporation (BRKR) worth $34.49 M, representing 0.06% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in BRKR, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2017, adding 1.1 M shares. Largest reduction occurred in Q1 2019, reducing 731,282 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +188,200 | New Buy | 188,200 | $18.47 |
| Q2 2015 | -165,200 | Reduce 87.78% | 23,000 | $20.39 |
| Q3 2015 | -23,000 | Sold Out | 23,000 | $0.00 |
| Q4 2016 | +48,800 | New Buy | 48,800 | $21.19 |
| Q1 2017 | +1.1 M | Add 2261.89% | 1.15 M | $23.33 |
| Q2 2017 | -536,000 | Reduce 46.50% | 616,600 | $28.84 |
| Q3 2017 | +50,800 | Add 8.24% | 667,400 | $29.75 |
| Q4 2017 | -667,400 | Sold Out | 667,400 | $0.00 |
| Q1 2018 | +525,000 | New Buy | 525,000 | $29.92 |
| Q2 2018 | +179,600 | Add 34.21% | 704,600 | $29.04 |
| Q3 2018 | -704,600 | Sold Out | 704,600 | $0.00 |
| Q4 2018 | +1.32 M | New Buy | 1.32 M | $29.77 |
| Q1 2019 | -731,282 | Reduce 55.46% | 587,248 | $38.44 |
| Q2 2019 | -410,449 | Reduce 69.89% | 176,799 | $49.95 |
| Q3 2019 | -64,065 | Reduce 36.24% | 112,734 | $43.93 |
| Q4 2019 | -32,440 | Reduce 28.78% | 80,294 | $50.98 |
| Q1 2020 | -21,149 | Reduce 26.34% | 59,145 | $35.86 |
| Q2 2020 | +39,755 | Add 67.22% | 98,900 | $40.68 |
| Q3 2020 | +134,920 | Add 136.42% | 233,820 | $39.75 |
| Q4 2020 | -233,820 | Sold Out | 233,820 | $0.00 |
| Q2 2021 | +70,860 | New Buy | 70,860 | $75.98 |
| Q3 2021 | -24,867 | Reduce 35.09% | 45,993 | $78.10 |
| Q4 2021 | -45,993 | Sold Out | 45,993 | $0.00 |
| Q2 2022 | +231,286 | New Buy | 231,286 | $62.76 |
| Q3 2022 | +257,998 | Add 111.55% | 489,284 | $53.06 |
| Q4 2022 | +126,358 | Add 25.83% | 615,642 | $68.35 |
| Q1 2023 | -375,468 | Reduce 60.99% | 240,174 | $78.84 |
| Q2 2023 | -238,811 | Reduce 99.43% | 1,363 | $73.92 |
| Q3 2023 | +272,437 | Add 19988.04% | 273,800 | $62.30 |
| Q4 2023 | -273,800 | Sold Out | 273,800 | $0.00 |
| Q2 2024 | +571,572 | New Buy | 571,572 | $63.81 |
| Q3 2024 | -327,776 | Reduce 57.35% | 243,796 | $69.06 |
| Q4 2024 | -243,796 | Sold Out | 243,796 | $0.00 |
| Q3 2025 | +1.06 M | New Buy | 1.06 M | $32.49 |
Steven Cohen's Bruker Corporation Investment FAQs
Steven Cohen first purchased Bruker Corporation (BRKR) in Q1 2015, acquiring 188,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Bruker Corporation (BRKR) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to Bruker Corporation (BRKR) was in Q4 2018, adding 1,318,530 shares worth $39.25 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,061,631 shares of Bruker Corporation (BRKR), valued at approximately $34.49 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bruker Corporation (BRKR) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in Bruker Corporation (BRKR) was 1,318,530 shares, as reported at the end of Q4 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.